HealthCare Global Enterprises Limited has released the Monitoring Agency report for the quarter ended March 31, 2026. The report confirms that there have been no deviations from the objects of the Rights Issue, which raised a total of ₹424.68 crore. As of the end of the quarter, there has been nil utilization of the proceeds, and the company maintains a clear alignment with its initial disclosure plans.
Quarterly Progress Overview
Following the successful conclusion of its Rights Issue, HealthCare Global Enterprises Limited has submitted its first monitoring report for the period ending March 31, 2026. The total proceeds of ₹424.68 crore remain intact as of the quarter’s end, with nil utilization reported across all specified project objects during the fourth quarter of the 2026 financial year.
Utilization of Proceeds
The company designated the funds for three primary objectives. These include the pre-payment or repayment of borrowings (allocated ₹170.00 crore), the acquisition of an additional 34% stake in Vizag Hospital and Cancer Research Center Private Limited (allocated ₹154.04 crore), and general corporate purposes (allocated ₹95.57 crore). An additional ₹5.07 crore was earmarked for issue-related expenses. All projects are currently in the initial stages with no delays reported.
Operational Notes
The report includes a clarification regarding a minor amount of ₹4,096 that was temporarily held due to an issue in a customer’s bank account. This discrepancy was resolved, and the funds were fully realized and transferred to the designated monitoring account by April 15, 2026. The Monitoring Agency, CARE Ratings Limited, has confirmed that the company’s deployment of unutilized proceeds is strictly following the established banking arrangements.
Source: BSE
